Symbol="ADMP"
AssetType="Common Stock"
Name="Adamis Pharma"
Description="Adamis Pharmaceuticals Corporation, a specialty biopharmaceutical company, develops and markets products in the therapeutic areas of allergies and respiratory diseases in the United States. The company is headquartered in San Diego, California."
CIK="887247"
Exchange="NASDAQ"
Currency="USD"
Country="USA"
Sector="LIFE SCIENCES"
Industry="PHARMACEUTICAL PREPARATIONS"
Address="11682 EL CAMINO REAL, SUITE 300, SAN DIEGO, CA, US"
FiscalYearEnd="December"
LatestQuarter="2023-06-30"
MarketCapitalization="6585500"
EBITDA="-17794120"
PERatio="None"
PEGRatio="0"
BookValue="-4.238"
DividendPerShare="0"
DividendYield="0"
EPS="-10.2"
RevenuePerShareTTM="2.222"
ProfitMargin="0"
OperatingMarginTTM="-3.736"
ReturnOnAssetsTTM="-1.045"
ReturnOnEquityTTM="-7.85"
RevenueTTM="5021700"
GrossProfitTTM="-1431408"
DilutedEPSTTM="-10.2"
QuarterlyEarningsGrowthYOY="0"
QuarterlyRevenueGrowthYOY="-0.826"
AnalystTargetPrice="0.42"
TrailingPE="-"
ForwardPE="-"
PriceToSalesRatioTTM="17.64"
PriceToBookRatio="8.62"
EVToRevenue="15.59"
EVToEBITDA="-0.784"
Beta="1.208"
num_52WeekHigh="26.18"
num_52WeekLow="0.77"
num_50DayMovingAverage="1.802"
num_200DayMovingAverage="8.15"
SharesOutstanding="7590400"
DividendDate="None"
ExDividendDate="None"
symbol="ADMP"
open="0.78"
high="0.84"
low="0.77"
price="0.83"
volume="266953.00"
latest_trading_day="2023-08-25"
previous_close="0.78"
change="0.05"
change_percent="6.1282%"
aroon_positive_momentum_days="0"
aroon_negative_momentum_days="99"
trend_strength="Absent or Weak Trend"
buying_signal="Weak Sell Signal"
volume_analysis="Trending High"
value_analysis="Bullish Trend"
Aroon_change="FALSE"
Aroon_momentum="1"
Volume_recent_avg="1939718"
Change_recent_avg="0.01"
Delta_recent_avg="0.23"
Variance_recent_avg="0.11"
Change_ratio_recent_avg="-2.12"
RSI_change="FALSE"
ADX_change="FALSE"

event="FALSE"
Aroon_signal="negative"
Aroon_change="FALSE"
Aroon_momentum_positive="1"
Aroon_momentum_negative="99"
image_negative_thumbnail_id_1="1086"
image_negative_url_1="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Negative_Landscape_0119.jpeg"
image_negative_thumbnail_id_2="94"
image_negative_url_2="https://hehge.com/wp-content/uploads/sites/16/2023/05/MI_Finance_Negative_Landscape_0082.jpeg"
image_neutral_thumbnail_id_1="527"
image_neutral_url_1="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Neutral_Landscape_0072.jpeg"
image_neutral_thumbnail_id_2="432"
image_neutral_url_2="https://hehge.com/wp-content/uploads/sites/16/2023/05/MI_Finance_Neutral_Landscape_0019.jpeg"
image_positive_thumbnail_id_1="1004"
image_positive_url_1="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Positive_Landscape_0166.jpeg"
image_positive_thumbnail_id_2="676"
image_positive_url_2="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Positive_Landscape_0032.jpeg"
image_professor_thumbnail_id_1="1177"
image_professor_url_1="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Professor_Landscape_0011.jpeg"
image_professor_thumbnail_id_2="1201"
image_professor_url_2="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Professor_Landscape_0035.jpeg"
